BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 8833657)

  • 1. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
    Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A
    Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.
    Lee JS; Weiss J; Martin JL; Scott CD
    Int J Cancer; 2003 Nov; 107(4):564-70. PubMed ID: 14520693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors.
    Osipo C; Dorman S; Frankfater A
    Exp Cell Res; 2001 Apr; 264(2):388-96. PubMed ID: 11262195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor and insulin receptors in intestinal mucosa of neonatal calves.
    Georgiev IP; Georgieva TM; Pfaffl M; Hammon HM; Blum JW
    J Endocrinol; 2003 Jan; 176(1):121-32. PubMed ID: 12525256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing the mannose 6-phosphate/IGF-II receptor differentially affects tumorigenic properties of normal breast epithelial cells.
    Caixeiro NJ; Martin JL; Scott CD
    Int J Cancer; 2013 Dec; 133(11):2542-50. PubMed ID: 23686499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the relative abundance of mRNA transcripts for insulin-like growth factor (IGF-I and IGF-II) ligands and their receptors (IGF-IR/IGF-IIR) in preimplantation bovine embryos derived from different in vitro systems.
    Yaseen MA; Wrenzycki C; Herrmann D; Carnwath JW; Niemann H
    Reproduction; 2001 Oct; 122(4):601-10. PubMed ID: 11570968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
    J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localization of insulin-like growth factor system in corpus luteum during different stages of estrous cycle in water buffaloes (Bubalus bubalis) and the effect of insulin-like growth factor I on production of vascular endothelial growth factor and progesterone in luteal cells cultured in vitro.
    Uniyal S; Panda RP; Chouhan VS; Yadav VP; Hyder I; Dangi SS; Gupta M; Khan FA; Sharma GT; Bag S; Sarkar M
    Theriogenology; 2015 Jan; 83(1):58-77. PubMed ID: 25304995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
    J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of IGF receptors and its ligands in bovine oocytes and preimplantation embryos.
    Wang LM; Feng HL; Ma YZh; Cang M; Li HJ; Yan Zh; Zhou P; Wen JX; Bou S; Liu DJ
    Anim Reprod Sci; 2009 Aug; 114(1-3):99-108. PubMed ID: 19013732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin-like growth factor II and its receptor gene expression in the endometrium of women with unexplained infertility].
    Wu RJ; Zhou FZ
    Zhonghua Fu Chan Ke Za Zhi; 2004 Apr; 39(4):242-5. PubMed ID: 15130350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
    Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
    Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying insulin-like growth factor action: How mutations in the GH: IGF axis lead to short stature.
    Forbes BE
    Pediatr Endocrinol Rev; 2011 Jun; 8(4):374-81. PubMed ID: 21972777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.